summary
Introduced
02/28/2018
02/28/2018
In Committee
02/28/2018
02/28/2018
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
Expanding Access to Low Cost Generic Drugs Act
AI Summary
This bill, the Expanding Access to Low Cost Generic Drugs Act, aims to amend the Federal Food, Drug, and Cosmetic Act to ensure that valid generic drugs can enter the market more easily. It does this by making changes to the 180-day exclusivity period for the first generic applicant, including defining the criteria for "first applicant" status and limiting agreements between generic applicants and brand-name drug manufacturers that could delay the entry of generic competition. The bill also requires generic drug companies to notify the FDA of any such agreements, and establishes the 45-day period for patent infringement lawsuits as the exclusive remedy for such lawsuits.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 02/28/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/115th-congress/senate-bill/2476/all-info |
| BillText | https://www.congress.gov/115/bills/s2476/BILLS-115s2476is.pdf |
| Bill | https://www.congress.gov/115/bills/s2476/BILLS-115s2476is.pdf.pdf |
Loading...